[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100582134":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":38,"responsibleParty":107,"collaborators":110,"id":114,"slug":115,"hasResults":116,"nctId":117,"briefTitle":118,"officialTitle":118,"acronym":119,"eligibilityCriteria":120,"healthyVolunteers":116,"sex":121,"minAge":12,"maxAge":12,"enrollmentInfo":122,"targetDuration":12,"studyType":125,"phases":126,"briefSummary":128,"conditions":129,"keywords":131,"overallStatus":41,"whyStopped":12,"lastUpdateSubmitDate":136,"lastUpdatePostDateStruct":137,"startDateStruct":140,"completionDateStruct":142,"leadSponsor":144,"locationsCount":145},{"fullName":5,"class":6},"Washington University School of Medicine","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Control Phase: For capturing baseline parameters.","NO_INTERVENTION","In the control phase, baseline data including postpartum BP measurement, treatment at enrollment and BP at 6- and 12-weeks follow-up will be recorded. BP control rates, and clinical outcomes will also be recorded.",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Intervention Phase: Participants will crossover to the intervention phase after 12 months.","EXPERIMENTAL","After a period of 12 months when all sites are in the control phase, crossover into the intervention phase will begin. The multilevel intervention will be the HDP Implementation Bundle. Patient education will be provided at time of participants' enrollment. This will cover knowledge of normal BP parameters, complications of HDP, warning symptoms, and advice on appropriate measures to take. A free automated BP monitor (e.g., Omron Series 3) will be provided and patients will be trained on BP measurement and instructed to report daily BP recordings via text messaging (similar to our feasibility study). Additionally, there will be a standardized follow-up interval (determined by Aim 1 results) for all patients with HDP and provision of free antihypertensive medications, if needed.",[18],"Other: Hypertension Disorders of Pregnancy (HDP) Implementation Bundle",[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":12},"Hypertension Disorders of Pregnancy (HDP) Implementation Bundle","The HDP Implementation Bundle will consist of 4 main blocks namely; patient education, home BP monitoring, a contextualized follow-up protocol and provision of free anti-hypertensives if need. Collectively, these will lead to design and development of a contextualized home BP monitoring program.",[14],[25],{"name":26,"affiliation":5,"role":27},"Zainab Mahmoud, MD, MSc","PRINCIPAL_INVESTIGATOR",[29,34],{"name":30,"role":31,"phone":32,"phoneExt":12,"email":33},"Dike Ojji, MBBS, PhD","CONTACT","+234-806-009-4456","dike.ojji@uniabuja.edu.ng",{"name":35,"role":31,"phone":36,"phoneExt":12,"email":37},"Kamilu Karaye, MBBS, PhD","+2348037042171","kkaraye@yahoo.co.uk",[39,63,76,92],{"facility":40,"status":41,"city":42,"state":12,"zip":12,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"National Hospital, Abuja","RECRUITING","Abuja","Nigeria","NG",{"type":46,"coordinates":47},"Point",[48,49],7.49508,9.05785,{"lat":49,"lon":48},[52,56,60],{"name":53,"role":31,"phone":54,"phoneExt":12,"email":55},"Elizabeth Tomilola-Emmanuel, MBBS","+2348133910560","tomilolaemmanuel@yahoo.com",{"name":57,"role":31,"phone":58,"phoneExt":12,"email":59},"Adaego Ameth Orji, MBBS","+23480637996563","princessego2019@gmail.com",{"name":61,"role":62,"phone":12,"phoneExt":12,"email":12},"Elizabeth Tomiloloa -Emmanuel, MBBS","SUB_INVESTIGATOR",{"facility":64,"status":41,"city":42,"state":12,"zip":12,"country":43,"countryCode":44,"cosmosGeoPoint":65,"geoPoint":67,"contacts":68},"University of Abuja Teaching Hospital",{"type":46,"coordinates":66},[48,49],{"lat":49,"lon":48},[69,71,75],{"name":30,"role":31,"phone":70,"phoneExt":12,"email":33},"234-806-009-4456",{"name":72,"role":31,"phone":73,"phoneExt":12,"email":74},"Francis Okoye, MBBS","+2348105979116","chukwuebukafrancisokoye@yahoo.com",{"name":30,"role":62,"phone":12,"phoneExt":12,"email":12},{"facility":77,"status":41,"city":78,"state":12,"zip":12,"country":43,"countryCode":44,"cosmosGeoPoint":79,"geoPoint":83,"contacts":84},"Aminu Kano Teaching Hospital","Kano",{"type":46,"coordinates":80},[81,82],8.51672,12.00012,{"lat":82,"lon":81},[85,87,91],{"name":35,"role":31,"phone":86,"phoneExt":12,"email":37},"+2348037042171.",{"name":88,"role":31,"phone":89,"phoneExt":12,"email":90},"Kabeer Karaye, MBBS","+2349036670008","kabeerkaraye@gmail.com",{"name":35,"role":62,"phone":12,"phoneExt":12,"email":12},{"facility":93,"status":41,"city":78,"state":12,"zip":12,"country":43,"countryCode":44,"cosmosGeoPoint":94,"geoPoint":96,"contacts":97},"Murtala Muhammad Specialist Hospital",{"type":46,"coordinates":95},[81,82],{"lat":82,"lon":81},[98,102,106],{"name":99,"role":31,"phone":100,"phoneExt":12,"email":101},"Hadiza Saidu, MBBS","+2348033238333","hsaidu2006@yahoo.com",{"name":103,"role":31,"phone":104,"phoneExt":12,"email":105},"Noura Idrees, MBBS","+2348065868650","nouridrees1@gmail.com",{"name":99,"role":62,"phone":12,"phoneExt":12,"email":12},{"type":27,"investigatorFullName":108,"investigatorTitle":109,"investigatorAffiliation":5,"oldNameTitle":12,"oldOrganization":12},"Zainab Mahmoud","Assistant Professor of Medicine",[111],{"name":112,"class":113},"National Heart, Lung, and Blood Institute (NHLBI)","NIH","100582134","improving-maternal-cardiovascular-outcomes-through-the-implementation-of-a-hypertensive-disorders-of-pregnancy-bundle-in-nigeria-100582134",false,"NCT06859359","Improving Maternal Cardiovascular Outcomes Through the Implementation of a Hypertensive Disorders of Pregnancy Bundle in Nigeria","IMPACT-HDP","Inclusion Criteria:\n\n* Postpartum adults (\\>18 years)\n* postpartum emancipated minors (in accordance with the Nigerian guidelines for young persons' participation in research and reproductive health services)\n* with diagnosis of HDP prior to delivery delivered at one of the participating sites able to provide informed consent.\n\nExclusion Criteria:\n\n* unable to provide consent.","FEMALE",{"count":123,"type":124},1200,"ESTIMATED","INTERVENTIONAL",[127],"NA","The goal of this interventional study is to learn from patients and healthcare providers at 4 health institutions (study sites) in Abuja and Kano in Nigeria what ways to best develop the content of a Hypertensive Disorders of Pregnancy ( HDP) Management package for pregnant women, and evaluate the effectiveness of implementing this package in improving cardiovascular health of pregnant women. The main question it aims to answer is:\n\nWill a contextualized home BP monitoring program lead to better BP control among patients with HDP in Nigeria?",[130],"Hypertensive Disorder of Pregnancy",[132,133,134,135],"Hypertension","Pregnancy","Preeclampsia","HDP","2026-03-25",{"date":138,"type":139},"2026-03-30","ACTUAL",{"date":141,"type":139},"2024-08-08",{"date":143,"type":124},"2029-06",{"name":5,"class":6},4]